The global nanoemulsions market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for nanoemulsions in various industries such as pharmaceuticals, cosmetics, and food industry. The increasing demand for nanoemulsions in these industries is due to their ability to provide enhanced efficacy and safety compared with conventional emulsion systems. The global nanoemulsions market by type is segmented into steroids, anesthetics, NSAIDs, immunosuppressant, antiretroviral drugs (ARVs), antimicrobials (antibiotics), vasodilators and others (e.g., anti-inflammatory agents). Steroids are expected to account for the largest share of the global nanoemulsions market during the forecast period owing to their wide range of applications in various fields such as dermatology and ophthalmology.
Industry Growth Insights published a new data on “Nanoemulsions Market”. The research report is titled “Nanoemulsions Market research by Types (Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, Others, Nanoemulsion), By Applications (Pharmaceutical Industry, Cosmetic Industry, Food Industry), By Players/Companies Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical, GlaxoSmithKline, Novartis AG, Sanofi, B. Braun Melsungen, Nanoemulsion”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nanoemulsions Market Research Report
By Type
Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, Others, Nanoemulsion
By Application
Pharmaceutical Industry, Cosmetic Industry, Food Industry
By Companies
Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical, GlaxoSmithKline, Novartis AG, Sanofi, B. Braun Melsungen, Nanoemulsion
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
233
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Nanoemulsions Market Report Segments:
The global Nanoemulsions market is segmented on the basis of:
Types
Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials, Vasodilators, Others, Nanoemulsion
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industry, Cosmetic Industry, Food Industry
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Allergan plc
- AbbVie Inc.
- AstraZeneca Inc.
- Fresenius Kabi AG
- Kaken Pharmaceutical
- GlaxoSmithKline
- Novartis AG
- Sanofi
- B. Braun Melsungen
- Nanoemulsion
Highlights of The Nanoemulsions Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Steroids
- Anesthetics
- NSAIDs
- Immunosuppressant
- Antiretroviral
- Antimicrobials
- Vasodilators
- Others
- Nanoemulsion
- By Application:
- Pharmaceutical Industry
- Cosmetic Industry
- Food Industry
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nanoemulsions Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nanoemulsions are a type of water-in-oil emulsion. They are created when oil and water droplets are suspended in an aqueous medium. Nanoemulsions have unique properties that make them useful in many applications, including cosmetics, pharmaceuticals, food and beverage products.
Some of the major companies in the nanoemulsions market are Allergan plc, AbbVie Inc., AstraZeneca Inc., Fresenius Kabi AG, Kaken Pharmaceutical, GlaxoSmithKline, Novartis AG, Sanofi, B. Braun Melsungen, Nanoemulsion.
The nanoemulsions market is expected to register a CAGR of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nanoemulsions Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nanoemulsions Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nanoemulsions Market - Supply Chain
4.5. Global Nanoemulsions Market Forecast
4.5.1. Nanoemulsions Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nanoemulsions Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nanoemulsions Market Absolute $ Opportunity
5. Global Nanoemulsions Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nanoemulsions Market Size and Volume Forecast by Type
5.3.1. Steroids
5.3.2. Anesthetics
5.3.3. NSAIDs
5.3.4. Immunosuppressant
5.3.5. Antiretroviral
5.3.6. Antimicrobials
5.3.7. Vasodilators
5.3.8. Others
5.3.9. Nanoemulsion
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nanoemulsions Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nanoemulsions Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical Industry
6.3.2. Cosmetic Industry
6.3.3. Food Industry
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nanoemulsions Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nanoemulsions Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nanoemulsions Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nanoemulsions Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nanoemulsions Demand Share Forecast, 2019-2026
9. North America Nanoemulsions Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nanoemulsions Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nanoemulsions Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical Industry
9.4.2. Cosmetic Industry
9.4.3. Food Industry
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nanoemulsions Market Size and Volume Forecast by Type
9.7.1. Steroids
9.7.2. Anesthetics
9.7.3. NSAIDs
9.7.4. Immunosuppressant
9.7.5. Antiretroviral
9.7.6. Antimicrobials
9.7.7. Vasodilators
9.7.8. Others
9.7.9. Nanoemulsion
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nanoemulsions Demand Share Forecast, 2019-2026
10. Latin America Nanoemulsions Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nanoemulsions Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nanoemulsions Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical Industry
10.4.2. Cosmetic Industry
10.4.3. Food Industry
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nanoemulsions Market Size and Volume Forecast by Type
10.7.1. Steroids
10.7.2. Anesthetics
10.7.3. NSAIDs
10.7.4. Immunosuppressant
10.7.5. Antiretroviral
10.7.6. Antimicrobials
10.7.7. Vasodilators
10.7.8. Others
10.7.9. Nanoemulsion
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nanoemulsions Demand Share Forecast, 2019-2026
11. Europe Nanoemulsions Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nanoemulsions Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nanoemulsions Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical Industry
11.4.2. Cosmetic Industry
11.4.3. Food Industry
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nanoemulsions Market Size and Volume Forecast by Type
11.7.1. Steroids
11.7.2. Anesthetics
11.7.3. NSAIDs
11.7.4. Immunosuppressant
11.7.5. Antiretroviral
11.7.6. Antimicrobials
11.7.7. Vasodilators
11.7.8. Others
11.7.9. Nanoemulsion
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nanoemulsions Demand Share, 2019-2026
12. Asia Pacific Nanoemulsions Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nanoemulsions Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nanoemulsions Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical Industry
12.4.2. Cosmetic Industry
12.4.3. Food Industry
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nanoemulsions Market Size and Volume Forecast by Type
12.7.1. Steroids
12.7.2. Anesthetics
12.7.3. NSAIDs
12.7.4. Immunosuppressant
12.7.5. Antiretroviral
12.7.6. Antimicrobials
12.7.7. Vasodilators
12.7.8. Others
12.7.9. Nanoemulsion
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nanoemulsions Demand Share, 2019-2026
13. Middle East & Africa Nanoemulsions Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nanoemulsions Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nanoemulsions Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical Industry
13.4.2. Cosmetic Industry
13.4.3. Food Industry
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nanoemulsions Market Size and Volume Forecast by Type
13.7.1. Steroids
13.7.2. Anesthetics
13.7.3. NSAIDs
13.7.4. Immunosuppressant
13.7.5. Antiretroviral
13.7.6. Antimicrobials
13.7.7. Vasodilators
13.7.8. Others
13.7.9. Nanoemulsion
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nanoemulsions Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Nanoemulsions Market: Market Share Analysis
14.2. Nanoemulsions Distributors and Customers
14.3. Nanoemulsions Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Allergan plc
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AbbVie Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AstraZeneca Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Fresenius Kabi AG
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Kaken Pharmaceutical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GlaxoSmithKline
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Novartis AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sanofi
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. B. Braun Melsungen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Nanoemulsion
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook